SD

Sandeep Devu Kamble

Active Director Designated Partner DIN 08992365
DIN 08992365 First appointment Dec 2020 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Sandeep Devu Kamble

Data last updated:

Sandeep Devu Kamble is a Designated Partner at Maestro Pharma Llp (since 2020). The company operates in Business Services.

DIN 08992365
Primary Designation Designated Partner
Industry Business Services
First Appointment 11 Dec 2020
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner11 Dec 20202020Active

Board colleagues of Sandeep Devu Kamble

NameDINCompanyDesignation
Akshay Chandrakant Kokitkar07891195Maestro Pharma LlpDesignated Partner
Pankaj Shivajirao Patil08992366Maestro Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Maestro Pharma Llp
Premium access

Shareholding and investment profile for Sandeep Devu Kamble

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandeep Devu Kamble

Sandeep Devu Kamble currently holds 1 directorship: Maestro Pharma Llp (Designated Partner, since 11 Dec 2020).

Sandeep Devu Kamble was first appointed on 11 Dec 2020 as Designated Partner at Maestro Pharma Llp.

The current boards of Sandeep Devu Kamble's companies include Akshay Chandrakant Kokitkar (Maestro Pharma Llp), Pankaj Shivajirao Patil (Maestro Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available